Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases), and by Region, Global trends and forecast from 2022 to 2029

1. Introduction
   1. Market Definition
   2. Market Segmentation
   3. Research Timelines
   4. Assumptions and Limitations
2. Research Methodology
   1. Data Mining
      1. Secondary Research
      2. Primary Research
      3. Subject-Matter Experts’ Advice
   2. Quality Checks
      1. Final Review
   3. Data Triangulation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Research Flow
   4. Data Sources
3. Executive Summary
4. Market Overview
   1. Global Gene Therapy Market Outlook
      1. Market Drivers
      2. Market Restraints
      3. Market Opportunities
   2. Impact of Covid-19 On Gene Therapy Market
   3. Porter’s five forces model
      1. Threat from new entrants
      2. Threat from substitutes
      3. Bargaining power of suppliers
      4. Bargaining power of customers
      5. Degree of competition
   4. Industry value chain Analysis
5. Global Gene Therapy Market by Vector Type (USD Million)
   1. Viral Vector
   2. Non-Viral Vector
6. Global Gene Therapy Market by Gene Type (USD Million)
   1. Antigen
   2. Cytokine
   3. Tumor Suppressor
   4. Suicide
   5. Deficiency
   6. Growth Factors
   7. Receptors
7. Global Gene Therapy Market by Application (USD Million)
   1. Oncological Disorders
   2. Rare Diseases
   3. Cardiovascular Diseases
   4. Neurological Disorders
   5. Infectious Disease
8. Global Gene Therapy Market by Region (USD Million)
   1. North America
      1. US
      2. Canada
      3. Mexico
   2. South America
      1. Brazil
      2. Argentina
      3. Colombia
      4. Rest Of South America
   3. Europe
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest Of Europe
   4. Asia Pacific
      1. India
      2. China
      3. Japan
      4. South Korea
      5. Australia
      6. South-East Asia
      7. Rest Of Asia Pacific
   5. Middle East and Africa
      1. UAE
      2. Saudi Arabia
      3. South Africa
      4. Rest Of Middle East and Africa
9. Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
   1. Adaptimmune Therapeutics Plc.
   2. Anchiano Therapeutics Ltd.
   3. Achieve Life Sciences, Inc.
   4. Adverum Biotechnologies, Inc.
   5. Abeona Therapeutics Inc.
   6. Applied Genetic Technologies Corporation
   7. Arbutus Biopharma Corporation
   8. Audentes Therapeutics, Inc.
   9. AveXis, Inc.
   10. Bluebird Bio, Inc.
   11. Epeius Biotechnologies
   12. Sanofi *The Company List Is Indicative

LIST OF TABLES

TABLE 1                GLOBAL GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 2                GLOBAL GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 3                GLOBAL GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 4                GLOBAL GENE THERAPY MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 5                US GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 6                US GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 7                US GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 8               CANADA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 9                CANADA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 10             CANADA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 11             MEXICO GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 12             MEXICO GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 13             MEXICO GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 14             BRAZIL GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 15             BRAZIL GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 16             BRAZIL GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 17             ARGENTINA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 18             ARGENTINA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 19             ARGENTINA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 20             COLOMBIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 21             COLOMBIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 22             COLOMBIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 23             REST OF SOUTH AMERICA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 24             REST OF SOUTH AMERICA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 25             REST OF SOUTH AMERICA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 26             INDIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 27             INDIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 28             INDIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 29             CHINA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 30             CHINA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 31             CHINA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 32             JAPAN GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 33             JAPAN GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 34             JAPAN GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 35             SOUTH KOREA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 36             SOUTH KOREA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 37             SOUTH KOREA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 38             AUSTRALIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 39             AUSTRALIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 40             AUSTRALIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 41             SOUTH-EAST ASIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 42             SOUTH-EAST ASIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 43             SOUTH-EAST ASIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 44             REST OF ASIA PACIFIC GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 45             REST OF ASIA PACIFIC GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 46             REST OF ASIA PACIFIC GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 47             GERMANY GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 48             GERMANY GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 49             GERMANY GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 50             UK GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 51             UK GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 52             UK GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 53             FRANCE GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 54             FRANCE GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 55             FRANCE GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 56             ITALY GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 57             ITALY GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 58             ITALY GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 59             SPAIN GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 60             SPAIN GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 61             SPAIN GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 62             RUSSIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 63             RUSSIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 64             RUSSIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 65             REST OF EUROPE GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 66             REST OF EUROPE GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 67             REST OF EUROPE GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 68             UAE GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 69             UAE GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 70             UAE GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 71             SAUDI ARABIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 72             SAUDI ARABIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 73             SAUDI ARABIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 74             SOUTH AFRICA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 75             SOUTH AFRICA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 76             SOUTH AFRICA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 77             REST OF MIDDLE EAST AND AFRICA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 78             REST OF MIDDLE EAST AND AFRICA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 79             REST OF MIDDLE EAST AND AFRICA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

LIST OF FIGURES

FIGURE 1             MARKET DYNAMICS

FIGURE 2             MARKET SEGMENTATION

FIGURE 3             REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4             DATA TRIANGULATION

FIGURE 5             BOTTOM-UP APPROACH

FIGURE 6             TOP-DOWN APPROACH

FIGURE 7             RESEARCH FLOW

FIGURE 8             GLOBAL GENE THERAPY MARKET BY VECTOR TYPE, USD MILLION, 2019-2028

FIGURE 9             GLOBAL GENE THERAPY MARKET BY GENE TYPE, USD MILLION, 2019-2028

FIGURE 10           GLOBAL GENE THERAPY MARKET BY APPLICATION, USD MILLION, 2019-2028

FIGURE 11           GLOBAL GENE THERAPY MARKET BY REGION, USD MILLION, 2019-2028

FIGURE 12           PORTER’S FIVE FORCES MODEL

FIGURE 13           NORTH AMERICA GENE THERAPY MARKET SNAPSHOT

FIGURE 14           EUROPE GENE THERAPY MARKET SNAPSHOT

FIGURE 15           ASIA PACIFIC GENE THERAPY MARKET SNAPSHOT

FIGURE 16           SOUTH AMERICA GENE THERAPY MARKET SNAPSHOT

FIGURE 17           MIDDLE EAST & AFRICA GENE THERAPY MARKET SNAPSHOT

FIGURE 18           ADAPTIMMUNE THERAPEUTICS PLC.: COMPANY SNAPSHOT

FIGURE 19           ANCHIANO THERAPEUTICS LTD.: COMPANY SNAPSHOT

FIGURE 20           ACHIEVE LIFE SCIENCES, INC.: COMPANY SNAPSHOT

FIGURE 21           ADVERUM BIOTECHNOLOGIES, INC.: COMPANY SNAPSHOT

FIGURE 22           ABEONA THERAPEUTICS INC.: COMPANY SNAPSHOT

FIGURE 23           APPLIED GENETIC TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT

FIGURE 24           ARBUTUS BIOPHARMA CORPORATION: COMPANY SNAPSHOT

FIGURE 25           AUDENTES THERAPEUTICS, INC.: COMPANY SNAPSHOT

FIGURE 26           AVEXIS, INC.: COMPANY SNAPSHOT

FIGURE 27           BLUEBIRD BIO, INC.: COMPANY SNAPSHOT

FIGURE 28           EPEIUS BIOTECHNOLOGIES: COMPANY SNAPSHOT